- Research article
- Open Access
Fidelity of end joining in mammalian episomes and the impact of Metnase on joint processing
© Rath et al.; licensee BioMed Central Ltd. 2014
- Received: 29 October 2013
- Accepted: 12 March 2014
- Published: 22 March 2014
Double Stranded Breaks (DSBs) are the most serious form of DNA damage and are repaired via homologous recombination repair (HRR) or non-homologous end joining (NHEJ). NHEJ predominates in mammalian cells at most stages of the cell cycle, and it is viewed as ‘error-prone’, although this notion has not been sufficiently challenged due to shortcomings of many current systems. Multi-copy episomes provide a large pool of genetic material where repair can be studied, as repaired plasmids can be back-cloned into bacteria and characterized for sequence alterations. Here, we used EBV-based episomes carrying 3 resistance marker genes in repair studies where a single DSB is generated with virally-encoded HO endonuclease cleaving rapidly at high efficiency for a brief time post-infection. We employed PCR and Southern blot to follow the kinetics of repair and formation of processing intermediates, and replica plating to screen for plasmids with altered joints resulting in loss of chloramphenicol resistance. Further, we employed this system to study the role of Metnase. Metnase is only found in humans and primates and is a key component of the NHEJ pathway, but its function is not fully characterized in intact cells.
We found that repair of episomes by end-joining was highly accurate in 293 T cells that lack Metnase. Less than 10% of the rescued plasmids showed deletions. Instead, HEK293 cells (that do express Metnase) or 293 T transfected with Metnase revealed a large number of rescued plasmids with altered repaired joint, typically in the form of large deletions. Moreover, quantitative PCR and Southern blotting revealed less accurately repaired plasmids in Metnase expressing cells.
Our careful re-examination of fidelity of NHEJ repair in mammalian cells carrying a 3′ cohesive overhang at the ends revealed that the repair is efficient and highly accurate, and predominant over HRR. However, the background of the cells is important in establishing accuracy; with human cells perhaps surprisingly much more prone to generate deletions at the repaired junctions, if/when Metnase is abundantly expressed.
- Accuracy of DSB repair in mammalian cells
- Episomal model of NHEJ
- End- processing and re-ligation
- Metnase nuclease
- Joint accuracy
Double Stranded Breaks (DSBs), a serious type of chromosome damage are usually caused by exogenous agents such as ionizing radiation (IR), topoisomerase poisons, radiomimetic drugs like bleomycin and doxorubicin, or endogenous damages which arise as a result of cellular metabolism (free radicals and DNA replication errors or collapse of stalled forks). Programmed DSBs are also generated during processes such as V(D)J recombination of immunoglobulin genes and during allelic exchanges at meiosis or zygotic fusion. If misrepaired, DSBs can result in chromosomal translocations, oncogenesis, and genomic instability [1–3]. DSB repair can be broadly divided into two major pathways: homologous recombination (HR) and non-homologous end joining (NHEJ) . HR requires the presence of an intact homologous template, often a sister chromatid, which allows accurate repair of DSBs via a replicative intermediate and is the preferred mode of repair in S and G2 phase of cell-cycle . In contrast, NHEJ operates without the need for a template DNA; sometimes joining the ends with minimal processing, hence considered potentially erroneous/mutagenic. NHEJ is the predominant form of repair in mammalian system and had been shown to operate all throughout the cell cycle .
Currently used DSB repair assays have several shortcomings. Researchers employ several methods such as Ionizing radiation (IR), radiomimetic drugs, laser, and site-specific endonucleases for induction of DNA damage . Of note, γ-irradiation and drug induced damage foci are randomly dispersed and non-homogenous in nature. Lasers create localized but exceedingly strong DNA damage. In addition, different wavelengths of the laser largely determine the damaged end structures subsequently resulting in widely different kinetics of repair with differential protein requirement (for a review see [7, 8]). DSBs introduced with a nuclease are adequate for studies of the molecular/cellular mechanisms, but estimates of repair accuracy are problematic since these enzymes turn over slowly and thus selecting for erroneous processing of the ends that eliminate the target sequence. This is well-known for the Endonuclease I-SceI induced DSBs , a model that also suffers from the need of pre-integration of the target sequence, and often low cutting efficiency (either due to low transfection of the cell population or because of the chromosomal location of its target sequence). The Endonuclease I-Ppol also suffers from low cleavage efficiency because of its unique target location in the highly condensed and repetitive ribosomal DNA gene clusters. Furthermore, study of repair at defined genomic DSBs is problematic due to the difficulty in re-obtaining ‘clean clonal’ isolates for analysis in sufficient representation. Likewise, use of yeast as a model system to parlay mammalian NHEJ is not entirely acceptable. Yeast like Saccharomyces cerevisiae or Saccharomyces pombe lack many well established components of mammalian NHEJ, like DNA-PKcs and Artemis. To date, orthologs for newly discovered NHEJ components of human APLF, PNK, Metnase, and APTX have not been identified in yeast . Furthermore, HR is the preferred repair pathway in yeast, whereas NHEJ is the predominant pathway in mammalian cells . In yeast, IR-induced and endonuclease-induced DSBs are differentially processed in a cell cycle-dependent manner .
Hence, we set out to develop one model system to efficiently represent repair activities in mammalian cells in a physiological setting, with episomes. Repair of multi-copy plasmids provides a large pool of mostly uniform genetic material where the repair process can be studied [13–15]. We utilized the yeast HO endonuclease (a key component of the mechanism for mating-type switch in yeast) for use in mammalian cells. In this system, the HO endonuclease is expressed by a recombinant adenovirus resulting in cleavage of its target site (on episomes) with high efficiency (depending on the MOI), and repair occurs via simple end-joining during a time course of infection. We previously utilized a mouse mammary cell line containing a single integrated HO target site at a defined genomic location . Whereas, this has generated powerful and useful information, for example in terms of the effects of chromatin on generation of the DSB and in repair [16, 17], for other purposes the system is limiting. For instance, damage induced by IR or genotoxins results in multiple simultaneous DSBs instead of a single break, which immediately raises questions in terms of similarity of activation and deactivation of the DNA damage response (DDR). It is of significant interest to the field of mammalian DSB repair to develop a model system, where there is synchronous induction of multiple ‘homogeneous’ site-specific DSBs in a population, and then be able to stop the nuclease activity rapidly .
Different assays, such as treatment of pre-cleaved plasmids with cellular extracts or transfection of linearized DNA templates into mammalian cells have been employed to study several different aspects of end-joining (efficiency of joining of different DNA ends, fidelity of repair [13, 19–21]). However, technical limitations prevent a clear picture from emerging regarding the end-joining efficiency/fidelity and nature of sequence rearrangements. For instance, Smith et al., using a transfection assay reported a similar efficiency of end-joining for different DNA ends. However, Poplawski et al., using cellular extracts have reported widely varying degree of efficiency of end-joining with different end structures [13, 22]. In fact, a recent report presented evidence for strikingly different repair efficiency using either lipid-based transfection vs. nucleofection . This highlights the importance of conducting end-joining assays in a ‘nearly unperturbed’ cellular environment. Where looked at repair fidelity of a DSB at an integrated chromosomal locus  most studies were limited in terms of low cleavage efficiency, absence of multiple defined site-specific DSB sites, and also the persistent activity of the nuclease employed. We thus wanted to investigate the repair fidelity in an episomal population. It is well established that EBV-based episomes become chromatinized and behave as minichromosomes [15, 25]. High density MNase maps for EBV-based episomes have been generated that have revealed highly positioned nucleosomes and putative origins of replication . Hence, repair studies of minichromosomes can also bring into focus the contribution of chromatin, closely resembling genomic damage. Finally, we wanted to characterize the effect of a recently identified important component of human NHEJ, known as Metnase, as an endonuclease on episomal repair fidelity in intact cells. Metnase has been shown to be a general facilitator of NHEJ increasing both accurate and inaccurate repair . Mutation of its nuclease domain has been shown to prevent this role, at least in a subset of end-joining events [28, 29]. Using in vitro assays, Metnase has been shown to have a preference for single stranded DNA overhang of a partially duplex molecule with an effect more pronounced on a 3′ overhang . Evidence from experiments done with plasmid-host cell transfection system, point to a significant role of Metnase in determining repaired junction fidelity for breaks with 3′ overhangs. Also, in a transfection assay coupled with integration, over-expression of Metnase did not significantly increase accurate NHEJ at the break site . Beck et al., reported a role of Metnase in promoting end-joining with non-compatible ends (both 5′ & 3′) in a cell free system . However, a very recent study reported against any functional role of Metnase in promoting end-joining of modified DNA ends using a similar cell free system . These contradictory findings hint towards a gap in knowledge regarding the role of Metnase as an endonuclease processing different ends , and even greater in intact cells. We wanted to determine the contribution of Metnase in altering repair fidelity (accurate vs. inaccurate repair) in our model system and to characterize the nature of nucleotide rearrangements to understand more in depth NHEJ fidelity in human cells.
Preparation of stable cell lines maintaining episomal HO-CAT plasmid
The 34 bp HO endonuclease target sequence (agatcttttagtttcagctttccgcaacagtata) was cloned in to the HindIII site of the pREP4/CAT shuttle vector just before the chloramphenicol acetyl transferase (CAT) coding sequence and the plasmid was renamed as HO-CAT plasmid. Further, HO-CAT plasmid was transfected in to 293 T cells which maintain the plasmid episomal due to presence of EBNA-1, under hygromycin selection (Hygromycin B/Calbiochem, Cat # 400052). The cell line was named 293 T-HO-CAT. Similarly HEK293 cells were transfected and selected to produce the 3-HO-CAT cell line. Metnase expressing pCAPP-Metnase-V5 plasmid which was prepared in Robert Hromas’ lab was transfected in to 293 T cells and puromycin (Puromycin Dihydrochloride/MP biomedicals, Cat # 100552) selected to produce the Metnase over expressing 293 T stable cell line. Subsequently, HO-CAT plasmid was transfected into these cells to produce the Met-T-HO-CAT cell line and maintained under dual selection of hygromycin and puromycin. GenePORTER (Genlantis, Cat # T201007) was used as the transfection reagent for all the above mentioned transfections. All the three cell lines were cultured using DMEM with 10% FCS as growth medium at 5% CO2 and 37°C.
Assay for DNA cleavage and repair
In a typical assay, for each different time point, 150,000 cells were infected with the recombinant adeno virus encoding HO endonuclease (Gift from Dr. Hamish Young, Columbia University, NY, USA) at 10–30 MOI, referred to as pPF446::HO in a plasmid map in . DNA from cells was collected using either Wizard SV genomic DNA purification system (Promega, Cat # A2360) or Wizard plus SV miniprep DNA purification (Promega,Cat # A1460) protocol. Equivalent amount of DNA was used in PCR and qPCR reactions for CAT and AMP regions using GoTaq DNA polymerase kit (Promega) and DynAmo Flash SYBR Green qPCR kit (Thermo Scientific, Cat # F-415S) respectively. 5′-CTACAACAAGGCAAGGCTTGACC-3′ and 5′-TCTAGTTGTGGTTTGTCCAAACTCATC-3′ were used as forward and reverse primers respectively for CAT amplicon. 5′-TTCCGTGTCGCCCTTATTCCC-3′ and 5′-GGCACCTATCTCAGCGATCTG-3′ were used as forward and reverse primers respectively for AMP region in PCR reactions. PCR conditions: 30 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 39 s with a final extension of 10 minutes at 72°C. The CAT signal was normalized to AMP signal. For qPCR, 5′-GTACCAGCTGCTAGCAAGCT-3′ and 5′-TCAACGGTGGTATATCCAGTGAT-3′ were used as forward and reverse primers respectively for the CAT region (amplicon size 133 bp). 5′-CATCGAACTGGATCTCAACAGCG-3′ and 5′-GTCATGCCATCCGTAAGATGCT-3′ were used as forward and reverse primers respectively for AMP region.
Protein samples from different time points were collected by RIPA lysis buffer (50 mM Tris pH 8.0, 0.1% SDS, 1% Triton-X, 1 mM EDTA, 150 mM NaCl, and with 1X protease inhibitors – SIGMAFAST protease inhibitor cocktail tablets, Cat # S8820) and quantitated using BCA protein assay kit (Pierce, Cat # 23223). Equal amounts were run on a 12% polyacrylamide gel, blotted on to Immobilon-P (Millipore, Cat # IPVH08100), and subsequently probed with anti-E3-11.6 K antibody (fusion protein with HO). The antibody was a kind gift from Dr. William S.M. Wold, St. Louis school of medicine, Missouri, USA. The blot was re-probed with Phospho- (S/T)Q-ATM/ATR substrate antibody (Cell Signaling, Cat # 2909S). Anti-Rabbit-HRP conjugated antibody (Cell signaling, cat # 7074S) was used as the secondary antibody. Stripping was done using Re-Blot plus mild (Millipore, Cat # 2502). The blot was either developed using Pierce ECL reagent (Thermo Scientific, Cat # 32106) or Opti-4CN (Bio-Rad, Cat # 170–8235).
NheI or NotI screening and bacterial transformation
Plasmids recovered from each different time point were subjected to NheI (or NotI) digestion (Promega, Cat # R6501) which has its recognition sequence very close to HO induced cleavage site. Subsequently, the enzyme was heat inactivated and the miniprep DNA was used to transform XL-1 Blue supercompetent cells (Agilent, Cat # 200236) and plated on an Ampicillin plate (100 μg/mL).
Replica plating assay
Plasmid DNA isolated from different cell lines at different time points was used to transform was incubated for 16 h at 37°C and subsequently replica plated on a chloramphenicol plate (50 μg/mL). Colonies were counted with Bio-Rad ChemiDoc (Cat # 170–8265) machine using Quantity-One software.
The HO-Luc plasmid was transfected using GenePORTER (Genlantis, Cat # T201007) and concomitantly infected with adeno-HO virus in either 293 T-HO-CAT cells or 293 T cells. At each time point, cells were taken of the plate and one aliquot of it was used to extract the DNA to be used for PCR to assay cleavage and repair. The rest of the cells were assayed for luminescence using Luciferase Assay system (Promega, Cat # E1501). GFP fluorescence was used to normalize the luminescence values. Both luminescence and fluorescence were measured by Synergy 4 plate reader by BioTEK instruments.
Southern Blotting for plasmid DNA
One fully confluent T75 flask was used for each time point. Plasmids were recovered using Zyppy plasmid Kit (Zymo Research, Cat # D4019). 10ug of plasmid DNA from each time point was digested with either Csp45I and NotI or Csp45I alone. Heat inactivated samples were run in 1% agarose-gel. Blotting onto Immobilon-Ny + (Millipore, Cat # INYC00010) was achieved using Trans-Blot SD semi-dry transfer cell (Biorad, Cat # 170–3957). EKONO hybridization buffer (Research Products International, Cat # 248800) was used for both pre-hybridization and hybridization. Hybridization probe was synthesized by random priming using random hexamers (Invitrogen, Cat # 51709) using whole plasmid DNA as template. Finally, the blot was exposed to X-ray films and developed using standard developer.
Preparation of cell extracts
About 1 million cells were used to prepare the whole cell extract for each mentioned time point. Cells were collected off the plate and washed once with cold 1X PBS. Subsequently, the cells are washed once with hypotonic buffer (25 mM Tris pH 7.9, 1 mM MgCl2, 0.4 mM CaCl2, and 0.5 mM DTT), spun down, and resuspended again in 200 μL of hypotonic buffer and kept in ice for 20 minutes. The cells were homogenized in a tight fitting Dounce homogenizer (30 strokes) and the debris was spun down by spinning at 13000 rpm for 10 minutes at 4°C. The supernatant is collected and used in the DNA cleavage reaction.
In vitro DNA cleavage assay
The reaction was carried out in a 10 μL reaction mixture with 250 ng of pMat-Puro plasmid, 6 mM MgCl2, 50 mM NaCl, 5 units of XmnI enzyme (Promega, Cat# R727A) (0.5 μL), and 2 μL cell extract for each given time. The mixture was incubated at 30°C for 1 h. Then, the reactions were stopped by adding 5 μL of stop solution (100 mM EDTA, 1% SDS, 1 mg/mL Proteinase K) and 3 μL of 6× loading dye and incubated at 55°C for 30 min-1 h. Then, the mixture was run in a 1% agarose gel.
Development of an episomal model system to study DSB repair
Kinetics of HO expression and inactivation
In Figure 2 we show a typical experiment with the kinetics of HO expression. In initial studies, we have observed a second cleavage cycle between 24-36 h Post-infection (PI) that could be explained by release of new virus and reactivation of the promoter driving HO expression in 293 T cells. For a study of repair fidelity, it is important to have the cleaving endonuclease transiently active. This reduces the bias toward inaccurate repair of the joint introduced in the system by the recurrent cutting and accurate restoration of the recognition sequence. In this context, Kaplun et al., have shown that HO is a target of Mec1/ATR mediated phosphorylation leading to its subsequent ubiquitination and degradation in yeast ; an obvious mechanism for haploid yeast to avoid repeated mating-type switching until the next cell division. We have previously shown that in a non-permissive cell system, HO expression shuts down by 3 h of infection, ensuring (mostly) a single round of cleavage/repair implicating the existence of a similar mechanism in mouse cells . In these cells (MM3MG mouse cells - non-permissive to human adeno virus) the HO protein, is expressed soon after infection leading to cleavage of its target site. But subsequently, ATM activation, and phosphorylation of HO results in its proteolytic loss with no new net synthesis , thus explaining absence of recurrent cutting of the restored target site and the enzyme is then degraded.
However, in a replication permissive system (human 293 T cells) HO nuclease persists throughout the infection (Figure 2A) due to a complex pattern of activation of early and late promoters usage  driving the E3/11.6-HO fusion . We should caution that the identification of this band, clearly a viral product, as the E3/11.6-HO fusion remains uncertain. Unfortunately a published HO antiserum is not available, and the way to detect the HO was through its fusion with the 11.6 k protein [32, 42], but previously presence of this product had been correlated with the nuclease activity . Assuming we have correctly identified the HO protein, however, it was unclear whether the HO enzyme remained active after cutting its target(s) or if it became nonetheless inactivated via its ATM/ATR-mediated phosphorylation. Maintenance of HO activity would elicit multiple rounds of cleavage and repair of the episomal targets, and the fundamental question was whether the pattern of repair (recovery of the CAT PCR product) was the result of a single round of cutting and repair, or a more complex pattern of cycles of cleavage and re-ligation. To answer this, first we determined that HO indeed became phosphorylated (by ATM/ATR) in this system, after we re-probed the HO-WB with a phospho-Ser/Thr (S/T) ATM/ATR substrate antibody (S/T-Q motif is the well characterized target of ATM/ATR substrates  and is also present in HO). Figure 2A shows rapid S/T-Q phosphorylation of the band co-migrating with HO that paralleled the cleavage of plasmid and the kinetics of ATM activation in this system  (Additional file 1: Figure S1). Treatment with λ phosphatase abolished the signal (not shown). In contrast, infection of plain 293 T cells showed a number of phospho-S/T-Q immune-reactive bands, but none that corresponded to the HO position or that corresponded to phospho-proteins induced after doxorubicin treatment (Additional file 2: Figure S2). In short, a possible scenario is that HO becomes S/T-Q phosphorylated after (maximal) cleavage of the bulk of episomes; and no longer seems to cleave until viral replication is complete and the next cycle of infection begins (the cells do not lyse until ~5-7 days later).
To confirm that HO is indeed inhibited following a single round of cleavage and repair, we performed two types of experiments, one with extract of HO-infected cells supplemented with a reporter plasmid exogenously and one in intact cells. We already knew by WBs that the HO fusion protein varies little throughout the time course of infection, but its activity seems to be limited to the first hour, after which the enzyme is phosphorylated by ATM/ATR and appears to be inhibited. We postulated that the source of ATM/ATR activation is the HO induced cleavage of HO-CAT episomes as shown previously (Figure 2 in ; Additional file 1: Figure S1). Hence, preparing the cell extract from Ad-HO infected 293 T cells not carrying the episomes would effectively avoid ATM/ATR activation, thus maintaining an active HO endonuclease. We thus prepared cell extract from both 293 T cells and cells carrying the episomes (T-HO-CAT cells) at different time points post infection with Ad-HO virus. As shown in Figure 2B, addition of pMat-puro plasmid (carrying a HO recognition site, ) to uninfected cell extract (lane 8) results in no appreciable cleavage (after 1 h of incubation in vitro). However, incubation in Ad-HO infected 293 T cell extracts collected at different time points results in complete linearization of the plasmid even after the first hour PI, and the HO activity remains so for the next 6 h, as judged by the appearance of cleaved product (we also added Xmn1 to these reactions to enhance the distinction between the linearized plasmid and the mobility of the relaxed circular form). In contrast, in cells carrying the pRep4-HO-CAT plasmid (labeled T-HO-CAT), the enzyme is active only for the first hour PI, but not after 4 h (note presence/absence of the cleaved product) (Figure 2B), indicating that the HO is inactive following cleavage of the endogenous episomes. Treatment of this ‘HO extract’ with λ phosphatase gave some return of cleavage but with unclear results as there was more plasmid smear (not shown).
High Fidelity repair of episomes via NHEJ
To summarize, deletions/insertions in the recovered plasmid population from T-HO-CAT cells at different time points during the course of repair was a very rare event and could only be detected in less than 10% of rescued plasmids.
Metnase promotes end-processing and erroneous repair
Study of early repair events and nucleolytic processing of the episomes after HO induced cleavage by Southern blotting
To probe the cleavage and repair of episomes at a molecular level, we resorted to southern blotting at different time points post-Ad-HO infection. Such a method is expected to emphasize the most prominent cleavage products obtained in the HO-infected population, to generate prototypical episomal processing patterns. The control plasmid (pREP4-HO-CAT from non-infected cells) was digested with Csp45I and NotI to yield bands of size close to 9Kb and 2Kb (N.I. 1st lane, Figure 7D). Plasmids rescued at different time points from infected cells were digested with Csp45I only (refer plasmid map in Figure 7C). As the NotI site is adjacent the HO site, we should expect to observe a similar banding pattern as for the control (1st lane) upon action by HO endonuclease. Figure 7D shows an expected cleavage pattern. Interestingly, we also observed a band migrating faster than the 9 Kb product (see 4 h time point, arrowhead) and a smaller species of approximately 1.5 kb that could represent further nucleolytic processing of DNA fragments following the initial HO cleavage.
In the presence of elevated Metnase expression (Met-T-HO-CAT cells), quantitatively the recovery of intact episomes after the given time window for repair (indicated as 11Kb band product) was less in comparison to episomes recovered from cells without Metnase (compare the 4 h and 6 h PI lanes; Figure 7D). Of note, we would like to remind that similar results were obtained with quantitative PCR showing that overexpression of Metnase delayed the kinetics of repair, resulting in diminished yield of repaired episomes for a given time point in comparison to control (Figure 6B), independently confirming the southern blot finding.
Sequencing of deleted clones obtained from Metnase over expressing cells revealed a recurrent pattern of DNA resection observed at the break site. Many clones lack a region of sequence, close to 200 bp in length, upstream of the cleavage site (leftward) while getting more heterogeneously resected (5′ to 3′ direction) on the other side of the DSB (Additional file 3: Supplementary text files 1 & 2). This is consistent with a very similar observation previously reported in yeast for HO induced breaks . There is remarkable similarity in terms of position and segment length of the missing region found on different clones, which are of different sizes. In this regard, it is worth mentioning a very recent report by Adkins et al., involving studies done with nucleosomal substrates, presented evidence for requirement of a nucleosome-free gap region adjacent to the DSB for Sgs1-Dna2 dependent resection machinery . Very recently, resection proteins Sgs1 and Exo1 have been also implicated in G1 checkpoint activation in budding yeast . Of note, a nucleosome plus the linker region is approximately 200 bp of DNA sequence. We also had made similar observations for precise removal of nucleosomal-length fragments at the single genomic HO-DSB in the MM3MG model when in the context of heterochromatin . This suggests the involvement of a common mechanism for providing a template more amenable for endonucleolytic processing, especially active in presence of Metnase. As a last observation we should note that the Southern blots also indicate that the repair mechanism appears to be predominantly accurate NHEJ (simple plasmid re-ligation) for these episomes, as we have rarely observed evidence of formation of concatemers, even when the population of plasmids was not completely cut, and thus offering intact template strands for HR between plasmid molecules, thus presumably resulting in Holliday junctions and concatemeric units that we were unable to detect on Southern blots. Even after presumably inhibiting NHEJ with a general inhibitor of PIKs (Wortmannin) or a more specific inhibitor of DNA-PKcs (KU55933) and hence shifting the balance more in favor of HRR, the majority of repair was again NHEJ and the proportion of concatemers (based on position of the gel) was hardly increased (Additional file 4: Figure S3). The Southern blot showed that NHEJ was inhibited by the KU55933 (reduction of the 11 kb re-ligated product) but there was only a modest shift toward formation of concatemers (generated via HRR).
In this report, we present results from an episomal model system to study end-joining process in intact mammalian cells upon induction of a DSB. This system is designed to overcome the limitations of existing DSB repair assays and gives the opportunity to evaluate end-joining fidelity of multiple DSBs in a single cell with 4 bp 3′ overhang in vivo. We also evaluated the role of Metnase and its contribution towards determining repair fidelity in this system. We found that > 90% of the recovered clones from the T-HO-CAT cells, which lack endogenous Metnase, are precisely rejoined indicating high fidelity of repair (Figure 4). This is in agreement with some previous reports indicating highly accurate NHEJ in mammalian cells [49–51]. In fact, a very recent report suggested the repair accuracy to be as high as 99% in a modified I-SceI mediated cleavage and repair assay and also showed precise ligation to be mediated by classical NHEJ components . However, Metnase expression may play a unique role in determining the fidelity of repair specifically in humans. Metnase is only known to be expressed in anthropoid primates (humans and apes). It has both histone methylase and DNA endonuclease activity and has been shown to promote NHEJ-mediated erroneous repair of DSBs (for a review ). Previous reports using cell extract based assays have been inconclusive in determining the exact role of Metnase in processing of DSBs with overhangs [29, 30]. Upon Metnase overexpression, we observed a 25-30% of inaccurately repaired plasmids by replica plating assay. Molecular analysis of recovered clones and direct southern blot results independently confirm this observation. This is suggestive of a prominent role of Metnase as an endonuclease for processing of DSBs. The southern blots specifically indicate a loss of full-length repaired products (compare 6 h time point of T-HO-CAT and Met-T-HO-CAT cells in Figure 7D). This is in accordance to a recent report using cellular extract where addition of Metnase did not increase yield of repaired products but resulted in increased resection and seemed to inhibit repair . However, by Southern blotting we also did not find evidence of a role for Metnase in preventing larger deletions (Figure 7B) as previously reported . These findings, along with evidence of clones with precise removal of a nucleosomal-length fragment at the left (5′ side) of the break may implicate a broader role of Metnase in determining the outcome of end-joining events in mammalian cells.
We have carried out a careful analysis of the fidelity of repair via NHEJ in mammalian cells using a high copy number episomal system that can be cleaved to generate homogeneous DSBs, and found that rather than error-prone, the repair was highly accurate in most cases. NHEJ was the predominant pathway of repair in this system, where the majority of plasmid was cleaved and leaving minimum number of intact copies for HR. The outcome of the accurate repair depended on presence of Metnase, a nuclease present in human cells, and which generated a pattern of discrete deletions near the DSB and resulting in much less accurate repair.
We thank Ms. Sharon Ronald and Mr. Sanket Awate for technical help and Dr. Brent Reed for help with designing the vector map.
This work was supported by grant W81XWH-10-1-0120 IDEA Development Award from the Department of Defense Prostate Cancer Research Program.
- Ciccia A, Elledge SJ: The DNA damage response: making it safe to play with knives. Mol Cell. 2010, 40 (2): 179-204. 10.1016/j.molcel.2010.09.019View ArticlePubMedPubMed CentralGoogle Scholar
- Helleday T, Lo J, van Gent DC, Engelward BP: DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst). 2007, 6 (7): 923-935. 10.1016/j.dnarep.2007.02.006View ArticleGoogle Scholar
- Jackson SP, Bartek J: The DNA-damage response in human biology and disease. Nature. 2009, 461 (7267): 1071-1078. 10.1038/nature08467View ArticlePubMedPubMed CentralGoogle Scholar
- Pardo B, Gomez-Gonzalez B, Aguilera A: DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship. Cell Mol Life Sci. 2009, 66 (6): 1039-1056. 10.1007/s00018-009-8740-3View ArticlePubMedGoogle Scholar
- Moynahan ME, Jasin M: Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol. 2010, 11 (3): 196-207. 10.1038/nrm2851View ArticlePubMedPubMed CentralGoogle Scholar
- Lieber M: The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010, 79: 181-211. 10.1146/annurev.biochem.052308.093131View ArticlePubMedPubMed CentralGoogle Scholar
- Nagy Z, Soutoglou E: DNA repair: easy to visualize, difficult to elucidate. Trends Cell Biol. 2009, 19 (11): 617-629. 10.1016/j.tcb.2009.08.010View ArticlePubMedGoogle Scholar
- Reynolds P, Botchway SW, Parker AW, O'Neill P: Spatiotemporal dynamics of DNA repair proteins following laser microbeam induced DNA damage - When is a DSB not a DSB?. Mutat Res. 2013, 756 (1-2): 14-20. 10.1016/j.mrgentox.2013.05.006View ArticlePubMedPubMed CentralGoogle Scholar
- Perrin A, Buckle M, Dujon B: Asymmetrical recognition and activity of the I-SceI endonuclease on its site and on intron-exon junctions. EMBO J. 1993, 12 (7): 2939-2947.PubMedPubMed CentralGoogle Scholar
- Polo SE, Jackson SP: Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 2011, 25 (5): 409-433. 10.1101/gad.2021311View ArticlePubMedPubMed CentralGoogle Scholar
- Sonoda E, Hochegger H, Saberi A, Taniguchi Y, Takeda S: Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair. 2006, 5 (9–10): 1021-1029.View ArticlePubMedGoogle Scholar
- Barlow JH, Lisby M, Rothstein R: Differential regulation of the cellular response to DNA double-strand breaks in G1. Mol Cell. 2008, 30 (1): 73-85. 10.1016/j.molcel.2008.01.016View ArticlePubMedPubMed CentralGoogle Scholar
- Smith J, Baldeyron C, De Oliveira I, Sala-Trepat M, Papadopoulo D: The influence of DNA double-strand break structure on end-joining in human cells. Nucleic Acids Res. 2001, 29 (23): 4783-4792. 10.1093/nar/29.23.4783View ArticlePubMedPubMed CentralGoogle Scholar
- Sen SP, De Benedetti A: TLK1B promotes repair of UV-damaged DNA through chromatin remodeling by Asf1. BMC Mol Biol. 2006, 7: 37- 10.1186/1471-2199-7-37View ArticlePubMedPubMed CentralGoogle Scholar
- Kumala S, Fujarewicz K, Jayaraju D, Rzeszowska-Wolny J, Hancock R: Repair of DNA strand breaks in a minichromosome in vivo: kinetics, modeling, and effects of inhibitors. PLoS One. 2013, 8 (1): e52966- 10.1371/journal.pone.0052966View ArticlePubMedPubMed CentralGoogle Scholar
- Sunavala-Dossabhoy G, De Benedetti A: Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair. DNA Repair. 2009, 8 (1): 87-102. 10.1016/j.dnarep.2008.09.005View ArticlePubMedGoogle Scholar
- Kanikarla-Marie P, Ronald S, De Benedetti A: Nucleosome resection at a double-strand break during Non-Homologous Ends Joining in mammalian cells - implications from repressive chromatin organization and the role of ARTEMIS. BMC Res Notes. 2011, 4: 13- 10.1186/1756-0500-4-13View ArticlePubMedPubMed CentralGoogle Scholar
- Deem AK, Li X, Tyler JK: Epigenetic regulation of genomic integrity. Chromosoma. 2012, 121 (2): 131-151. 10.1007/s00412-011-0358-1View ArticlePubMedPubMed CentralGoogle Scholar
- North P, Ganesh A, Thacker J: The rejoining of double-strand breaks in DNA by human cell extracts. Nucleic Acids Res. 1990, 18 (21): 6205-6210. 10.1093/nar/18.21.6205View ArticlePubMedPubMed CentralGoogle Scholar
- Chen S, Inamdar KV, Pfeiffer P, Feldmann E, Hannah MF, Yu Y, Lee JW, Zhou T, Lees-Miller SP, Povirk LF: Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity. J Biol Chem. 2001, 276 (26): 24323-24330. 10.1074/jbc.M010544200View ArticlePubMedGoogle Scholar
- Verkaik NS, Esveldt-van Lange RE, van Heemst D, Bruggenwirth HT, Hoeijmakers JH, Zdzienicka MZ, van Gent DC: Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur J Immunol. 2002, 32 (3): 701-709. 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-TView ArticlePubMedGoogle Scholar
- Poplawski T, Pastwa E, Blasiak J: Non-homologous DNA end joining in normal and cancer cells and its dependence on break structures. Genet Mol Biol. 2010, 33 (2): 368-373. 10.1590/S1415-47572010005000018View ArticlePubMedPubMed CentralGoogle Scholar
- Magin S, Saha J, Wang M, Mladenova V, Coym N, Iliakis G: Lipofection and nucleofection of substrate plasmid can generate widely different readings of DNA end-joining efficiency in different cell lines. DNA Repair. 2013, 12: 148-160. 10.1016/j.dnarep.2012.11.008View ArticlePubMedGoogle Scholar
- Guirouilh-Barbat J, Huck S, Bertrand P, Pirzio L, Desmaze C, Sabatier L, Lopez B: Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol Cell. 2004, 14 (5): 611-623. 10.1016/j.molcel.2004.05.008View ArticlePubMedGoogle Scholar
- Reeves R, Gorman CM, Howard B: Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res. 1985, 13 (10): 3599-3615. 10.1093/nar/13.10.3599View ArticlePubMedPubMed CentralGoogle Scholar
- Papior P, Arteaga-Salas JM, Günther T, Grundhoff A, Schepers A: Open chromatin structures regulate the efficiencies of pre-RC formation and replication initiation in Epstein-Barr virus. J Cell Biol. 2012, 198 (4): 509-528. 10.1083/jcb.201109105View ArticlePubMedPubMed CentralGoogle Scholar
- Hromas R, Wray J, Lee SH, Martinez L, Farrington J, Corwin LK, Ramsey H, Nickoloff JA, Williamson EA: The human set and transposase domain protein Metnase interacts with DNA Ligase IV and enhances the efficiency and accuracy of non-homologous end-joining. DNA Repair (Amst). 2008, 7 (12): 1927-1937. 10.1016/j.dnarep.2008.08.002View ArticleGoogle Scholar
- Lee SH, Oshige M, Durant ST, Rasila KK, Williamson EA, Ramsey H, Kwan L, Nickoloff JA, Hromas R: The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair. Proc Natl Acad Sci U S A. 2005, 102 (50): 18075-18080. 10.1073/pnas.0503676102View ArticlePubMedPubMed CentralGoogle Scholar
- Beck BD, Lee SS, Williamson E, Hromas RA, Lee SH: Biochemical characterization of metnase’s endonuclease activity and its role in NHEJ repair. Biochemistry. 2011, 50 (20): 4360-4370. 10.1021/bi200333kView ArticlePubMedPubMed CentralGoogle Scholar
- Mohapatra S, Yannone SM, Lee SH, Hromas RA, Akopiants K, Menon V, Ramsden DA, Povirk LF: Trimming of damaged 3’ overhangs of DNA double-strand breaks by the Metnase and Artemis endonucleases. DNA Repair (Amst). 2013, 12 (6): 422-432. 10.1016/j.dnarep.2013.03.005View ArticleGoogle Scholar
- Povirk LF: Processing of Damaged DNA Ends for Double-Strand Break Repair in Mammalian Cells. ISRN Molecular Biology. 2012, 2012: 16-View ArticleGoogle Scholar
- Nicolas AL, Munz PL, Falck-Pedersen E, Young CS: Creation and repair of specific DNA double-strand breaks in vivo following infection with adenovirus vectors expressing Saccharomyces cerevisiae HO endonuclease. Virology. 2000, 266 (1): 211-224. 10.1006/viro.1999.0062View ArticlePubMedGoogle Scholar
- Middleton T, Sugden B: Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1. J Virol. 1994, 68 (6): 4067-4071.PubMedPubMed CentralGoogle Scholar
- Ronald S, Awate S, Rath A, Carroll J, Galiano F, Dwyer D, Kleiner-Hancock H, Mathis JM, Vigod S, De Benedetti A: Phenothiazine Inhibitors of TLKs Affect Double-Strand Break Repair and DNA Damage Response Recovery and Potentiate Tumor Killing with Radiomimetic Therapy. Genes Cancer. 2013, 4: 39-53. 10.1177/1947601913479020View ArticlePubMedPubMed CentralGoogle Scholar
- Deckbar D, Birraux J, Krempler A, Tchouandong L, Beucher A, Walker S, Stiff T, Jeggo P, Lobrich M: Chromosome breakage after G2 checkpoint release. J Cell Biol. 2007, 176 (6): 749-755. 10.1083/jcb.200612047View ArticlePubMedPubMed CentralGoogle Scholar
- Huang LC, Clarkin KC, Wahl GM: Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc Natl Acad Sci U S A. 1996, 93 (10): 4827-4832. 10.1073/pnas.93.10.4827View ArticlePubMedPubMed CentralGoogle Scholar
- Ben-Yehoyada M, Wang LC, Kozekov ID, Rizzo CJ, Gottesman ME, Gautier J: Checkpoint signaling from a single DNA interstrand crosslink. Mol Cell. 2009, 35 (5): 704-715. 10.1016/j.molcel.2009.08.014View ArticlePubMedPubMed CentralGoogle Scholar
- Goodarzi A, Jeggo P, Lobrich M: The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax. DNA Repair. 2010, 9: 1273-1282. 10.1016/j.dnarep.2010.09.013View ArticlePubMedGoogle Scholar
- Kaplun L, Ivantsiv Y, Kornitzer D, Raveh D: Functions of the DNA damage response pathway target Ho endonuclease of yeast for degradation via the ubiquitin-26S proteasome system. Proc Natl Acad Sci. 2000, 97 (18): 10077-10082. 10.1073/pnas.97.18.10077View ArticlePubMedPubMed CentralGoogle Scholar
- Canfield C, Rains J, De Benedetti A: TLK1B promotes repair of DSBs via its interaction with Rad9 and Asf1. BMC Mol Biol. 2009, 10: 110- 10.1186/1471-2199-10-110View ArticlePubMedPubMed CentralGoogle Scholar
- Pahl HL, Sester M, Burgert HG, Baeuerle PA: Activation of transcription factor NF-kappaB by the adenovirus E3/19 K protein requires its ER retention. J Cell Biol. 1996, 132 (4): 511-522. 10.1083/jcb.132.4.511View ArticlePubMedGoogle Scholar
- Tollefson AE, Ryerse JS, Scaria A, Hermiston TW, Wold WS: The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology. 1996, 220 (1): 152-162. 10.1006/viro.1996.0295View ArticlePubMedGoogle Scholar
- Kim ST, Lim DS, Canman CE, Kastan MB: Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem. 1999, 274 (53): 37538-37543. 10.1074/jbc.274.53.37538View ArticlePubMedGoogle Scholar
- Ronald S, Sunavala-Dossabhoy G, Adams L, Williams B, De Benedetti A: The expression of tousled kinases in CaP cell lines and its relation to radiation response and DSB repair. Prostate. 2011, 71: 1367-1373. 10.1002/pros.21358View ArticlePubMedGoogle Scholar
- Wray J, Williamson EA, Sheema S, Lee SH, Libby E, Willman CL, Nickoloff JA, Hromas R: Metnase mediates chromosome decatenation in acute leukemia cells. Blood. 2009, 114 (9): 1852-1858. 10.1182/blood-2008-08-175760View ArticlePubMedPubMed CentralGoogle Scholar
- Lee SE, Moore JK, Holmes A, Umezu K, Kolodner RD, Haber JE: Saccharomyces Ku70, mre11/rad50 and RPA proteins regulate adaptation to G2/M arrest after DNA damage. Cell. 1998, 94 (3): 399-409. 10.1016/S0092-8674(00)81482-8View ArticlePubMedGoogle Scholar
- Adkins NL, Niu H, Sung P, Peterson CL: Nucleosome dynamics regulates DNA processing. Nat Struct Mol Biol. 2013, 20: 836-842. 10.1038/nsmb.2585View ArticlePubMedPubMed CentralGoogle Scholar
- Balogun FO, Truman AW, Kron SJ: DNA resection proteins Sgs1 and Exo1 are required for G1 checkpoint activation in budding yeast. DNA Repair. 2013, 12 (9): 751-760. 10.1016/j.dnarep.2013.06.003View ArticlePubMedPubMed CentralGoogle Scholar
- Adams BR, Hawkins AJ, Povirk LF, Valerie K: ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells. Aging (Albany NY). 2010, 2 (9): 582-596.PubMed CentralGoogle Scholar
- Jiang G, Plo I, Wang T, Rahman M, Cho JH, Yang E, Lopez BS, Xia F: BRCA1-Ku80 protein interaction enhances end-joining fidelity of chromosomal double-strand breaks in the G1 phase of the cell cycle. J Biol Chem. 2013, 288 (13): 8966-8976. 10.1074/jbc.M112.412650View ArticlePubMedPubMed CentralGoogle Scholar
- Honma M, Sakuraba M, Koizumi T, Takashima Y, Sakamoto H, Hayashi M: Non-homologous end-joining for repairing I-SceI-induced DNA double strand breaks in human cells. DNA Repair (Amst). 2007, 6 (6): 781-788. 10.1016/j.dnarep.2007.01.004View ArticleGoogle Scholar
- Lin WY, Wilson JH, Lin Y: Repair of chromosomal double-strand breaks by precise ligation in human cells. DNA Repair (Amst). 2013, 12 (7): 480-487. 10.1016/j.dnarep.2013.04.024View ArticleGoogle Scholar
- Shaheen M, Williamson E, Nickoloff J, Lee SH, Hromas R: Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation. Genetica. 2010, 138 (5): 559-566. 10.1007/s10709-010-9452-1View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.